Matthew Helbling says the turning point in his pharmacy career came when he took on a pilot program for medication therapy management—and discovered the power of connecting more deeply with patients.
Matthew Helbling, Pharm.D., director of clinical effectiveness and operations at Prime Therapeutics LLC, is one of this year’s Managed Healthcare Executive Emerging Leaders in Healthcare.
MHE editors asked each leader to answer three questions in a video interview: Describe a turning point in your career; if you could change one thing about U.S. healthcare, what would it be; and what is a personal goal you’re working toward outside of your professional life?
Helbling said a defining moment early in his career came when he was working in retail pharmacy and offered the chance to pilot a medication therapy management (MTM) program.
"I was fairly unfamiliar with the process and what it would all entail but took on that pilot and was able to start doing comprehensive medication reviews with my current patients," he said, adding that he was able to spend more time building relationships with patients at a deeper level—becoming part of their care team.
That experience led him to seek out a role at Prime Therapeutics as an MTM pharmacist, which has since grown into leadership opportunities focused on strategy and large-scale impact.
When it comes to improving U.S. healthcare, Helbling says the biggest barrier is patient understanding.
"The healthcare system as a whole is difficult to navigate," he said. "I think that we find that patients and members that we speak to just don't have a lot of information or education around the benefits available to them and the community resources that are available to them."
He believes the system needs to do more to flag useful information, improve follow-up for new members, and clearly explain how to access support.
Outside of work, Helbling is looking forward to enjoying the short but beautiful summer season in Minnesota.
"In the summer, I will be learning how to wake surf," he shared. “So that will be an exciting and hopefully not too challenging venture for me this year.”
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Report: Cyberattacks Have Impacted Patient Care, Nearly 20% of Healthcare Leaders Say
June 5th 2025Although 52% of healthcare leaders believe a fatal cyber-related patient incident will happen within the next five years, cybersecurity was not ranked as a top business challenge, according to the results of Omega Systems’ 2025 Healthcare IT Landscape Report.
Read More
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Kathryn Boger, Ph.D. | 2025 MHE Emerging Leaders in Healthcare
June 5th 2025Co-founder and chief clinical officer, InStride Health. InStride Health provides evidence-based care for children, teens and young adults with anxiety and obsessive-compulsive disorder (OCD) and their families.
Read More
FDA Approved Bayer’s Nubeqa for Metastatic Castration-Sensitive Prostate Cancer
June 5th 2025The approval is based on results from the phase 3 ARANOTE trial, which showed Nubeqa, when combined with androgen deprivation therapy (ADT), reduced the risk of radiographic progression or death by 46% compared to ADT with placebo.
Read More